Clinical Trial

IMPLEMENTING PATIENTS' COMPETENCE IN ORAL EBC THERAPY PERSISTENCE

Study acronym: IMPACT PT
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this interventional study is to evaluate the effect of standardized patient coaching on treatment adherence among patients taking abemaciclib. The main question it aims to answer is, whether standardized coaching leads to patients taking abemaciclib much more consistently. Researchers will therefore compare therapy adherence of patients receiving standardized coaching to patients receiving routine care. Participants will be asked to answer several questionnaires.
Trial Details
NCT Number NCT07521202
Lead Sponsor Institut fuer Frauengesundheit
Collaborators: Lilly Deutschland GmbH Germany
Conditions HR+/HER2- Early Breast Cancer
Enrollment 257 participants
Start Date 2026-06
Primary Completion 2029-06 (estimated)
Study Completion 2030-06 (estimated)
Updated on ClinicalTrials.gov 2026-04-09